Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Michael Diamond and Xuping Xie.
Michael Diamond
Connection Strength
0.989
Xuping Xie
  1. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host Microbe. 2021 07 14; 29(7):1151-1161.e5.
    View in: PubMed
    Score: 0.238
  2. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
    View in: PubMed
    Score: 0.238
  3. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.233
  4. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021 08; 596(7870):109-113.
    View in: PubMed
    Score: 0.060
  5. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. JACC Basic Transl Sci. 2021 Apr; 6(4):331-345.
    View in: PubMed
    Score: 0.058
  6. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 2021 04 15; 184(8):2229-2238.e13.
    View in: PubMed
    Score: 0.058
  7. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
    View in: PubMed
    Score: 0.058
  8. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.